# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Aims To Improve Patient Quality Of Life For Those With Spinal Cord And Brain Injuries, Multi-Trauma, Amputations, Stroke, Multi...
Lake Street analyst Ben Haynor initiates coverage on Ekso Bionics Holdings (NASDAQ:EKSO) with a Buy rating and announces Pri...
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Ekso Bionics Holdings (NASDAQ:EKSO) with a Buy and raises t...
Ekso Bionics Holdings (NASDAQ:EKSO) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate ...
The Dow Jones index closed lower by more than 100 points on Thursday. When insiders purchase or sell shares, it indicates their...
Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expect...